SLFN11 and esophageal squamous cell carcinoma: [72] Thus, it is possible that the observed SLFN11-dependent improvement in clinical outcome in esophageal squamous cell carcinoma may reflect the improved response of tumors expressing high SLFN11 to platinum but not 5-fluorouracil.